Work

P3.02c-038 First-Line Atezolizumab plus Chemotherapy in Chemotherapy-Naïve Patients with Advanced NSCLC: A Phase III Clinical Program

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.11.1833

Authors: Frederico Cappuzzo, Martin Reck, Vassiliki Papadimitrakopoulou, Robert Jotte, Howard West, Tony Mok, Alan Sandler, Simonetta Mocci, Shelley Coleman, Takashi Asakawa, Mark Socinski

Institutions: Ospedale di Livorno, German Center for Lung Research, LungenClinic Grosshansdorf, The University of Texas MD Anderson Cancer Center, Rocky Mountain Cancer Centers, Swedish Medical Center, Chinese University of Hong Kong, Genentech, Florida Hospital Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2541318045

FWCI: 0.241

Cites:

Cited by: 3

Related to: 10